BAM
Barrett Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $68.5M | Sell |
115,994
-3,950
| -3% | -$2.33M | 2.87% | 7 |
|
|
2021
Q4 | $80M | Buy |
119,944
+9,742
| +9% | +$6.5M | 3.02% | 8 |
|
|
2021
Q3 | $63M | Sell |
110,202
-821
| -0.7% | -$469K | 2.89% | 9 |
|
|
2021
Q2 | $56M | Sell |
111,023
-611
| -0.5% | -$308K | 2.58% | 10 |
|
|
2021
Q1 | $50.9M | Buy |
111,634
+176
| +0.2% | +$80.3K | 2.53% | 11 |
|
|
2020
Q4 | $51.9M | Sell |
111,458
-2,834
| -2% | -$1.32M | 2.72% | 9 |
|
|
2020
Q3 | $50.5M | Sell |
114,292
-63
| -0.1% | -$27.8K | 2.98% | 7 |
|
|
2020
Q2 | $41.4M | Sell |
114,355
-50
| -0% | -$18.1K | 2.65% | 8 |
|
|
2020
Q1 | $32.4M | Buy |
114,405
+1,150
| +1% | +$326K | 2.53% | 15 |
|
|
2019
Q4 | $36.8M | Buy |
113,255
+780
| +0.7% | +$253K | 2.25% | 14 |
|
|
2019
Q3 | $32.8M | Sell |
112,475
-350
| -0.3% | -$102K | 2.16% | 17 |
|
|
2019
Q2 | $33.1M | Buy |
112,825
+1,325
| +1% | +$389K | 2.19% | 16 |
|
|
2019
Q1 | $30.5M | Buy |
111,500
+395
| +0.4% | +$108K | 2.05% | 17 |
|
|
2018
Q4 | $24.9M | Buy |
111,105
+2,855
| +3% | +$639K | 1.91% | 21 |
|
|
2018
Q3 | $26.4M | Sell |
108,250
-380
| -0.3% | -$92.8K | 1.72% | 24 |
|
|
2018
Q2 | $22.5M | Buy |
108,630
+1,890
| +2% | +$392K | 1.53% | 26 |
|
|
2018
Q1 | $22M | Buy |
106,740
+4,205
| +4% | +$868K | 1.57% | 28 |
|
|
2017
Q4 | $19.5M | Buy |
102,535
+915
| +0.9% | +$174K | 1.37% | 28 |
|
|
2017
Q3 | $19.2M | Buy |
101,620
+7,335
| +8% | +$1.39M | 1.4% | 27 |
|
|
2017
Q2 | $16.5M | Buy |
+94,285
| New | +$16.5M | 1.24% | 31 |
|